Legend Biotech Corporation (NASDAQ:LEGN) Q2 2023 Earnings Conference Call August 15, 2023 8:00 AM ET

Company Participants

Jessie Yeung - Head of Investor Relations and Public Relations

Ying Huang - Chief Executive Officer

Lori Macomber - Chief Financial Officer

Steve Gavel - Senior Vice President, Commercial Development, Us and Europe

Guowei Fang - Chief Scientific Officer and Head of Business Development

Conference Call Participants

Kelly Shi - Jefferies

Terence Flynn - Morgan Stanley

Gena Wang - Barclays

Umer Raffat - Evercore

Yaron Werber - Cowen

Kostas Biliouris - BMO Capital

Justin Zelin - BTIG

Mitchell Kapoor - H.C. Wainwright

Brooke Schuster - William Blair

Kelsey Goodwin - Guggenheim

Operator

Good morning and thank you for standing by. Welcome to the Legend Biotech Reports Second Quarter 2023 Financial Results. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.

I would now like to turn the conference over to Jessie Yeung, Head of Investor Relations and Public Relations. Please go ahead.

Jessie Yeung

Good morning. This is Jessie Yeung, Head of Investor Relations and Public Relations at Legend Biotech. Thank you for joining our conference call today to review our second quarter 2023 performance.

Joining me on today's call are Ying Huang, our CEO; and Lori Macomber, Legend's CFO. Following the prepared remarks, we will open up the call for Q&A. We have Guowei Fang, Chief Scientific Officer, and Steve Gavel, Head of Commercial Development for the US and Europe joining the Q&A session.

During today's call we will be making forward-looking statements which are subject to risks and uncertainties that may cause our actual results to differ materially from those expressed or implied here within. These forward-looking statements are discussed in greater detail in our SEC filings, which we encourage you to read and can be found under the Investors section of our company website.

Thank you and I will now turn the call over to Ying.

Ying Huang

Good morning, everyone. Thank you for joining us today. We have had a very busy first half of the year and we're excited to be sharing our latest corporate developments with you on a quarterly basis starting with today's call.

Over the past six months, our teams have worked incredibly hard to accomplish a number of critical milestones that have set the stage for decisive growth for our company for years to come.